Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname.

Malaria journal - 11 Sept 2012

Adhin Malti R, Labadie-Bracho Mergiory, Vreden Stephen G

Abstract excerpt

BACKGROUND: Polymorphisms within the PfATP6 gene have been indicated as potential molecular markers for artemisinin efficacy. Since 2004, the use of artemisinin combination therapy (ACT) was introduced as first-line treatment of the uncomplicated malaria cases in Suriname. The aim of this research was to determine changes in Suriname in the status of the polymorphic markers in the PfATP6 gene before and after the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artemisinins
Share to Calcium-Transporting ATPases
Share to DNA, Protozoan

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Malaria, Falciparum

Share to Mutation, Missense

Share to Plasmodium falciparum

Share to Point Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 22966810
DOI: 10.1186/1475-2875-11-322
PMCID: PMC3468384

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname.PMID 22966810Read ↗

Molecular Profile of Malaria Drug Resistance Markers of Plasmodium falciparum in Suriname.Semantic proximity Read ↗

Molecular assessment of atpase6 mutations associated with artemisinin resistance among unexposed and exposed Plasmodium falciparum clinical isolates to artemisinin-based combination therapy.Semantic proximity Read ↗

Molecular surveillance as monitoring tool for drug-resistant Plasmodium falciparum in Suriname.Semantic proximity Read ↗

Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy.Semantic proximity Read ↗

Pfatp6 molecular profile of Plasmodium falciparum isolates in the western Brazilian Amazon.Semantic proximity Read ↗

Characterization of the Plasmodium falciparum sarcoplasmic/endoplasmic reticulum Ca2+-ATPase gene in samples from Equatorial Guinea before implementation of artemisinin-based combination therapy.Semantic proximity Read ↗

Detection of point mutation in Plasmodium falciparum ATPase6 gene associated with artemisinin resistance from Assam and Arunachal Pradesh.Semantic proximity Read ↗

Diversity of the sarco/endoplasmic reticulum Ca(2+)-ATPase orthologue of Plasmodium falciparum (PfATP6).Semantic proximity Read ↗

Genetic diversity and lack of artemisinin selection signature on the Plasmodium falciparum ATP6 in the Greater Mekong Subregion.Semantic proximity Read ↗

Polymorphism of PfATPase in Niger: detection of three new point mutationsSemantic proximity Read ↗

Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies.Semantic proximity Read ↗

Detecting adenosine triphosphatase 6 (pfATP6) point mutations that may be associated with Plasmodium falciparum resistance to artemisinin: prevalence at baseline, before policy change in Uganda.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.